Christopher D.T. Guiffre

2014

In 2014, Christopher D.T. Guiffre earned a total compensation of $831.1K as President and Chief Executive Officer at Cerulean Pharma, a 119% increase compared to previous year.

Compensation breakdown

Bonus$115,500
Option Awards$387,336
Salary$317,128
Other$11,168
Total$831,132

Guiffre received $387.3K in option awards, accounting for 47% of the total pay in 2014.

Guiffre also received $115.5K in bonus, $317.1K in salary and $11.2K in other compensation.

Rankings

In 2014, Christopher D.T. Guiffre's compensation ranked 8,370th out of 13,032 executives tracked by ExecPay. In other words, Guiffre earned more than 35.8% of executives.

ClassificationRankingPercentile
All
8,370
out of 13,032
36th
Division
Manufacturing
3,111
out of 4,966
37th
Major group
Chemicals And Allied Products
1,051
out of 1,686
38th
Industry group
Drugs
830
out of 1,365
39th
Industry
Pharmaceutical Preparations
643
out of 1,043
38th
Source: SEC filing on April 28, 2016.

Guiffre's colleagues

We found four more compensation records of executives who worked with Christopher D.T. Guiffre at Cerulean Pharma in 2014.

2014

Oliver Fetzer

Cerulean Pharma

Chief Executive Officer

2014

Edward Garmey

Cerulean Pharma

Chief Medical Officer

2014

Karen Roberts

Cerulean Pharma

Senior Vice President, Finance and Administration

2014

Alejandra Carvajal

Cerulean Pharma

General Counsel

You may also like